Navigation Links
SVS 2009: Ziehm Imaging Sets a New Standard in Mobile Imaging With the Ziehm Vision RFD
Date:6/10/2009

RIVERSIDE, California and NUREMBERG, Germany, June 10 /PRNewswire/ -- Ziehm Imaging is proud to announce that the United States Food and Drug Administration (FDA) has given 510k clearance for the latest innovative mobile C-arm from Ziehm Imaging, the Ziehm Vision(R) RFD, for marketing and sales within the United States. Designed for use in endovascular surgery, interventional cardiology and interventional radiology, the Ziehm Vision RFD mobile C-arm combines the latest flat-panel technology and a true fully digital imaging chain with a compact design that delivers exceptional image quality. During demanding procedures physicians will benefit from improved visualization, workflow and reduced radiation dose.

The Ziehm Vision RFD combines innovative flat-panel technology with the sophisticated ODDC (Object Detected Dose Control) software and special designed anatomical programs for excellent image quality at minimal dose. The flat-panel detector allows for fully digital, distortion-free imaging and better access to the patient due to the larger C-arm opening and the 165degrees orbital rotation. Thanks to pulse technology at up to 25 frames per second, the system provides sharp, high contrast images of vasculature, bone and soft tissue structures, which is indispensable particularly for complex applications in endovascular surgery. The excellent image quality, once only expected from fixed room systems, is now available in a mobile interventional suite.

Because of its compact design and the flat panel detector's increased field of view, the Ziehm Vision RFD provides physicians with a wide range of benefits. The 30 cm x 30 cm size of the flat panel detector and the 1.5 k x 1.5 k resolution provides extended dynamic range and 49% greater anatomical viewing, when compared to 12 inch image intensifier systems delivering comprehensive information about the patient's anatomy. With the added advantage of a smaller footprint, users receive the benefit of greater maneuverability. At the same time, the mobile interventional suite provides better access to the patient due to the larger C-arm opening and the 165degrees orbital rotation. Additionally with the Ziehm Vision RFD, user workflow is simplified and day-to-day clinical efficiency is improved through the innovative VisionCenter touchscreen user interface. Because of its excellent image quality and user friendliness, the Ziehm Vision RFD is suitable for a wide variety of clinical tasks, particularly for demanding procedures common in endovascular surgery, interventional radiology, and interventional cardiology.

Versatile imaging for greater efficiency in the operating theater

"Using fully digital technology, we are setting standards for C-arms in terms of image quality and patient care," comments Klaus Horndler, CEO of Ziehm Imaging. "The combination of digital imaging with Advanced Active Cooling and anatomical imaging modes opens a new chapter in intraoperative imaging by bringing fixed room image quality and throughput to the operating room in a mobile solution. Our aim is to evolve x-ray based imaging methods consistently so that we can provide physicians with the best possible technology to enable enhanced treatments."

Ziehm Imaging is presenting the Ziehm Vision RFD at the SVS congress in Denver, Co from June 11 - 13. You can find Ziehm Imaging in Booth 811.

(R) Registered Trademark in Germany and/or in the USA.

About Ziehm Imaging

Ziehm imaging specializes in the development, manufacturing and worldwide marketing of mobile x-ray-based imaging solutions. The company has been market leader in Germany for more than seven years as well as in many other European countries for two years. Today, Ziehm Imaging is a global systems provider, employing over 250 people worldwide. Extensive in-house development know-how is reflected in the Ziehm Imaging C-arms' high medical imaging performance, intelligent generator technology, significant dose savings and seamless digital network integration. Building on competence and creativity, as well as continuous dialog and close cooperation with renowned universities, research centers and hospitals, Ziehm Imaging has developed groundbreaking technologies that have made the company a global trendsetter in intelligent interventional imaging. Ziehm Imaging products are known for their outstanding versatility and their easy handling for a wide variety of medical applications. In addition, they offer seamless integration into existing IT environments for digital image data acquisition, image evaluation and image management. Please see http://www.ziehm.com for more information.

    Press release

    Ziehm Imaging, United States
    greg.mciff@ziehm.com
    Tel: +1-951-781-2020

    Ziehm Imaging Germany
    martin.herzmann@ziehm-eu.com
    Tel: +49-911-2172-302



'/>"/>
SOURCE Ziehm Imaging
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ESC Congress 2009: Worlds biggest cardiology meeting to be held in Barcelona
2. May 14, 2009: Biodesix Announces VeriStrat(R) Data in Head and Neck Cancer to be Presented at ASCO
3. American Transplant Congress 2009: New Investigator Forum Presents Cutting Edge Research
4. ESA to Launch Corona(R) ultra(TM) at Pittcon 2009: Booth #1080
5. Hospital Build Asia Exhibition and Congress 2009: Regions Most Comprehensive Healthcare Infrastructure Planning and Development Event to Debut in Singapore
6. National Heart Failure Awareness Week February 8-14, 2009: Visit www.abouthf.org to Learn More About Heart Failure
7. Lower Your Grocery Bill, Improve Health In 2009: Top Tips From Dr. Praegers Sensible Foods
8. Pharmacy Technician Certification Board (PTCB) Unveils New Testing Features for 2009: PTCB Exam to be Offered Daily; Test Results Given to Candidates Immediately in 2009
9. 2009: The Year of Health Care Reform? Faith-Based Investors See Doubling of Related Shareholder Resolutions, Growing Public Support From Corporate America
10. Nutrition Software nutrinote 2009: Lose Weight With the Help of a Computer
11. NewCardio to Present at OneMedForum 2009: Disrupters and Drivers on January 13 in San Francisco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... Boar’s Head Brand®, one of the nation’s leading ... Big Game. Take the stress out of your party preparation – follow these easy, ... every stage of the game. , “The key to hosting a successful game-day party ...
(Date:2/5/2016)... York, New York (PRWEB) , ... February 05, 2016 , ... ... announced the election of Patrick McDermott as Chairman of the National Board of Directors. ... Pat as Chairman of the Board,” stated Leslie A. Chambers , APDA President ...
(Date:2/5/2016)... ... 2016 , ... Stuart Bentkover, MD, FACS is thrilled to announce ... most effective tattoo removal today, Dr. Bentkover is the only doctor in Central Massachusetts ... PicoSure has been approved by the Food and Drug Administration (FDA) as a safe ...
(Date:2/5/2016)... ... , ... Colorize is a web theme package created exclusively for ... Colorize's dynamic moving camera. Colorize is perfect for personal and web related videos and ... 1 to 5 focus points per scene, stage floor scene presets that are great ...
(Date:2/5/2016)... ... , ... Health and wellness is a topic that should concern all Americans; ... experiencing an illness. Migraines are a severe form of a headache and often are ... wish the pain on their worst enemy, the feeling can last for many hours ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... 4, 2016 Mettler-Toledo International Inc. (NYSE: ... Provided below are the highlights: , Sales ... with the prior year.  Reported sales decreased 3% as ... , Net earnings per diluted share as reported ... year period.  Adjusted EPS was $4.65, an increase of ...
(Date:2/4/2016)... Md. , Feb. 4, 2016 In response ... , the FDA,s Deputy Commissioner for Medical Products and Tobacco, ... plan to reassess the agency,s approach to opioid medications. The ... while still providing patients in pain access to effective relief. ... FDA will: , Re-examine the risk-benefit paradigm for ...
(Date:2/4/2016)... , Feb. 4, 2016  Blueprint Medicines ... discovering and developing highly selective investigational kinase medicines ... the appointment to its board of directors of ... with nearly 30 years of industry-related experience. ... of Blueprint Medicines. "Lonnel,s strong strategic experience developing ...
Breaking Medicine Technology: